Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FormBlends vs Teleios Health

FormBlends
Graded #78

Higher grade

vs+12.400000000000006
Teleios Health
Graded #331

Lower grade

The verdict

FormBlends takes it — 72.4/100 to 60/100.

FormBlends grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FormBlends is a US direct-to-consumer brand selling compounded GLP-1 weight-loss medication — compounded semaglutide from $99 and compounded tirzepatide from $349 — dispensed by a licensed 503A pharmacy and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
83
83
Dose & formulationFormBlends +13
77
64
Clinical oversightFormBlends +27
76
49
Labs & monitoringFormBlends +4
52
48
FulfillmentFormBlends +32
74
42
Contract termsEven
55
55
FormBlends · left barTeleios Health · right bar

The numbers

MetricFormBlendsTeleios Health
WeighScore72.4/10060/100
GradeCC
Scorecard rank#78#331
Semaglutide$99/mo (compounded)$99/mo (starting dose, compounded)
Tirzepatide$349/mo (compounded)$139/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
FormBlends

Graded #78 · C

Strengths

  • Low published entry price on compounded semaglutide ($99) from a licensed 503A pharmacy
  • Physician-supervised program with 24/7 care-team access and free shipping over $150
  • Extensive free educational content, guides and provider comparisons on-site

Where it loses points

  • Enrollment and final pricing complete on an external portal (rx.formscripts.com), not fully on-site
  • $99 may be an intro rate; tirzepatide is comparatively high at $349/mo
  • State availability and LegitScript status not published; pharmacy is its own FormScripts brand
Teleios Health

Graded #331 · C

Strengths

  • Compounded semaglutide from $99/mo — among the lowest floor prices in cash-pay telehealth
  • Compounded tirzepatide from a competitive $139/mo floor
  • Markets physician (MD/DO) prescribing rather than an NP-only model
  • Clean meta-tag and SEO implementation

Where it loses points

  • Single-page app: state availability, pharmacy partner, dose pricing, lab requirements, and refund policy aren't visible and couldn't be verified
  • No named medical director, physician, or corporate entity disclosed
  • Year founded unknown — a newer floor-price entrant warranting extra scrutiny
  • No LegitScript, NABP, or SOC 2 trust signal found
  • Heavy paid-acquisition ad-tech stack — pair with diligence on the clinical layer

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard